Detection of fetomaternal hemorrhage

American Journal of Hematology

Volumn 87, Issue 4, 2012, Pages 417-423

  Kim, Yeowon A ^a   Makar, Robert S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ACCURACY; ALLOIMMUNIZATION; ANTIBODY PRODUCTION; ARTICLE; CELL SCREENING; CIRCULATION; ERYTHROCYTE; FETOMATERNAL TRANSFUSION; FETUS CIRCULATION; FLOW CYTOMETRY; FUNCTION TEST; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT MORTALITY; KLEIHAUER BETKE ACID ELUTION TEST; MATERNAL CIRCULATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROSETTE TEST; STANDARDIZATION;

ACIDS; FEMALE; FETAL BLOOD; FETAL HEMOGLOBIN; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; HUMANS; ISOANTIBODIES; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; ROSETTE FORMATION; SENSITIVITY AND SPECIFICITY; SOLUBILITY; STAINING AND LABELING;

EID: 84862818286     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22255     Document Type: Article

References (54)

1. Wylie BJ, D'Alton ME. Fetomaternal hemorrhage. Obstet Gynecol 2010; 115: 1039-1051.
2. Daniels G. Human Blood Groups. Chichester, England: Wiley-Blackwell; 2002. pp 247.
3. MacKenzie IZ, Roseman F, Findlay J. The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin. BJOG 2006; 113: 97-101.
4. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy. Br Med J 1974; 2: 75-80.
5. Sebring ES, Polesky HF. Fetomaternal hemorrhage: Incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990; 30: 344-357.
6. Ramsey G. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: Survey of laboratory practice. Arch Pathol Lab Med 2009; 133: 465-469.
7. Polesky HF, Sebring ES. Evaluation of methods for detection and quantitation of fetal cells and their effect on RhIgG usage. Am J Clin Pathol 1981; 76( 4 Suppl): 525-529.
8. Stedman CM, Baudin JC, White CA, Cooper ES. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women. Am J Obstet Gynecol 1986; 154: 1363-1369.
9. Bayliss KM, Kueck BD, Johnson ST, Fueger JT. Detecting fetomaternal hemorrhage: A comparison of five methods. Transfusion 1991; 31: 303-307.
10. Sebring ES, Polesky HF, Detection of fetal hemorrhage in Rh immune globulin candidates. A rosetting technique using enzyme-treated Rh2Rh2 indicator erythrocytes. Transfusion 1982; 22: 468-471.
11. Klein HG, Anstee DJ, eds. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Malden, MA: Blackwell; 2005.
12. Sandler SG, Sathiyamoorthy S. Laboratory methods for Rh immunoprophylaxis: A review. Immunohematology 2010; 26: 92-103.
13. Kleihauer E, Braun H, Betke K. [Demonstration of fetal hemoglobin in erythrocytes of a blood smear]. Klin Wochenschr 1957; 35: 637-638.
14. Creasy RK, Resnik R, Iams JD. Maternal-Fetal Medicine, 5th ed. Philadelphia, PA: W.B. Saunders Co. xviii; 2004. 1362
15. Mollison PL. Quantitation of transplacental haemorrhage. Br Med J 1972; 3: 31-34.
16. Cunningham FG, Williams JW. Williams Obstetrics, 20th ed. Stamford, CT: Appleton & Lange. viii; 1997. p 1448.
17. American Association of Blood Banks, Technical Manual of the American Association of Blood Banks, 16th ed. Washington, DC: AABB; 2008. p 985.
18. Foley MR, Strong TH, Garite TJ. Obstetric Intensive Care Manual, 2nd ed. New York: McGraw-Hill Medical; 2004.
19. Clayton EMJr, Feldhaus WD, Phythyon JM. The demonstration of fetal erythrocytes in the presence of adult red blood cells. Am J Clin Pathol 1963; 40: 487-490.
20. Clayton EMJr, Foster EB, Clayton EP. New stain for fetal erythrocytes in peripheral blood smears. Obstet Gynecol 1970; 35: 642-645.
21. Clayton EMJr, Robertson JC, Feldhaus WD. Antepartum and postpartum detection of fetal erythrocytes in maternal circulation. Obstet Gynecol 1962; 20: 608-610.
22. Clayton EMJr, Birdwell ED, Gregory MG. Fetal cell counting as a guide to prevention of Rh sensitization. Transfusion 1973; 13: 425-427.
23. Davis BH, Olsen S, Bigelow NC, Chen JC. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion 1998; 38: 749-756.
24. Porra V, Bernaud J, GueretIdentification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: Evaluation of the fetal cell count kit. Transfusion 2007; 47: 1281-1289.
25. Lafferty JD, Raby A, Crawford L. Fetal-maternal hemorrhage detection in Ontario. Am J Clin Pathol 2003; 119: 72-77.
26. Raafat A, Fraser N, Main R, Urbaniak SJ. A quality assurance scheme for the Kleihauer test: The Scottish experience 1988-1996. Transfus Med 1997; 7: 221-226.
27. Pelikan DM, Mesker WE, Scherjon SA. Improvement of the Kleihauer-Betke test by automated detection of fetal erythrocytes in maternal blood. Cytometry B Clin Cytom 2003; 54: 1-9.
28. Franco RS, Yasin Z, Palascak MB. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood 2006; 108: 1073-1076.
29. Garner C, Tatu T, Reittie JE. Genetic influences on F cells and other hematologic variables: A twin heritability study. Blood 2000; 95: 342-346.
30. Wood WG, Stamatoyannopoulos G, Lim G, Nute PE. F-cells in the adult: Normal values and levels in individuals with hereditary and acquired elevations of Hb F. Blood 1975; 46: 671-682.
31. Popat N, Wood WG, Weatherall DJ, Turnbull AC. Pattern of maternal F-cell production during pregnancy. Lancet 1977; 2: 377-379.
32. Duguid JK, Bromilow IM. Laboratory measurement of fetomaternal hemorrhage and its clinical relevance. Transfus Med Rev 1999; 13: 43-48.
33. Stropnicky EM, MacKenna J, Larkin E. Persistent hemoglobin F in donor blood may give falsely elevated acid-elution test in Rh-negative patient. Am J Obstet Gynecol 1982; 142: 109-110.
34. Krauss JS, Fadel HE, Squires J, Baisden CR. Detection of fetal-maternal hemorrhage in a mother with sickle trait and hereditary persistence of fetal hemoglobin. Transfusion 1983; 23: 530-531.
35. Weaver DL, Barthold JC, Hamill B. Hereditary persistence of fetal hemoglobin presenting as fetal-maternal hemorrhage. Am J Clin Pathol 1990; 93: 277-280.
36. Patton WN, Nicholson GS, Sawers AH. Assessment of fetal-maternal haemorrhage in mothers with hereditary persistence of fetal haemoglobin. J Clin Pathol 1990; 43: 728-731.
37. Goldman M, Blajchman MA, Ali MA. Overestimation of fetomaternal haemorrhage by the acid-elution technique in mothers with beta-thalassaemia minor. Transfus Med 1991; 1: 129-132.
38. Iyer R, McElhinney B, Heasley N. False positive Kleihauer tests and unnecessary administration of anti-D immunoglobulin. Clin Lab Haematol 2003; 25: 405-408.
39. Davis BH. Laboratory assessment of fetomaternal hemorrhage is improved using flow cytometry. LabMedicine 2007; 38: 365-371.
40. Bromilow IM, Duguid JK. Measurement of feto-maternal haemorrhage: A comparative study of three Kleihauer techniques and two flow cytometry methods. Clin Lab Haematol 1997; 19: 137-142.
41. Chen JC, Davis BH, Wood B, Warzynski MJ. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytometry 2002; 50: 285-290.
42. Chen JC, Bigelow N, Davis BH. Proposed flow cytometric reference method for the determination of erythroid F-cell counts. Cytometry 2000; 42: 239-246.
43. Pelikan DM, Scherjon SA, Mesker WE. Quantification of fetomaternal hemorrhage: A comparative study of the manual and automated microscopic Kleihauer-Betke tests and flow cytometry in clinical samples. Am J Obstet Gynecol 2004; 191: 551-557.
44. Ochsenbein-Imhof N, Ochsenbein AF, Seifert B. Quantification of fetomaternal hemorrhage by fluorescence microscopy is equivalent to flow cytometry. Transfusion 2002; 42: 947-953.
45. Lloyd-Evans P, Guest AR, Voak D, Scott ML. Detection of weak D and D(VI) red cells in D-negative mixtures by flow cytometry: Implications for feto-maternal haemorrhage quantification and D typing policies for newborns. Br J Haematol 1999; 104: 621-625.
46. Kumpel B. Are weak D RBCs really immunogenic? Transfusion 2006; 46: 1061-1062; discussion 1062-1066.
47. Schmidt PJ. Are weak D red blood cells really immunogenic? Transfusion 2006; 46: 2029-2030.
48. Mayne K, Bowell P, Woodward T. Rh immunization by the partial D antigen of category DVa. Br J Haematol 1990; 76( 4): 537-539.
49. Kumpel BM. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D. Transfusion 2001; 41: 1059-1063.
50. Kennedy GA, Shaw R, Just S. Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: Anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D. Transfus Med 2003; 13: 25-33.
51. Urbaniak SJ. The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol 1998; 105 ( Suppl 18): 11-18.
52. Radel DJ, Penz CS, Dietz AB, Gastineau DA. A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D. Transfusion 2008; 48: 1886-1891.
53. Little BH, Robson R, Roemer B, Scott CS. Immunocytometric quantitation of foeto-maternal haemorrhage with the Abbott Cell-Dyn CD4000 haematology analyser. Clin Lab Haematol 2005; 27: 21-31.
54. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003; 43: 1661-1666.